24Dec 2019

VITAMIN C AS A MARKER OF OXIDATIVE STRESS IN HYPERTENSION

  • Associate Professor, Department of Biochemistry , MGM Medical College, Aurangabad
  • Assistant Professor, Department of Biochemistry, MGM Medical College Aurangabad
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

The etiology of essential hypertension includes increased oxidative stress. Vitamin C is one of the potent reducing agents and scavenger of free radicals in biological systems. The role of benefit of vitamin C, an antioxidant to antihypertensive therapy were studied along with MDA level in comparison with control. It was found plasma ascorbic acid concentration to be inversely associated with systolic and diastolic BP in hypertensive subjects. A decrease in Vitamin C, an increase in malondialdehyde levels were observed in hypertensive group as compared to control. The increase in MDA and decrease in Vitamin C were statistically significant. Vitamin C or ascorbic acid is an antioxidant that may decrease the blood pressure (BP) and influence the endothelial dysfunction.


  1. Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type II diabetes. Clin Sci (Lond) 2002;103:339?44
  2. Jacques PF: A cross-sectional study of vitamin C intake and blood pressure in the elderly. Int J Vitam Nutr Res. 1992, 62 (3): 252-255.
  3. Jackson T.S., Xu A., Vita J.A., Keaney J.F., Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ. Res. 1998;83:916?922.
  4. Kim M.K., Sasaki S., Sasazuki S., Okubo S., Hayashi M., Tsugane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension. 2002;40:797?803.
  5. Magen E, Viskoper R, Mishal J, Priluk R, Berezovsky A, Laszt A, London D, Yosefy C. Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control. Isr Med Assoc J 2004;6:742?6
  6. Nightingale AK, Crilley JG, Pegge NC, Boehm EA, Mumford C, Taylor DJ, Styles P, Clarke K, Frenneaux MP. Chronic oral ascorbic acid therapy worsens skeletal muscle metabolism in patients with chronic heart failure. Eur J Heart Fail 2007;9:287?91
  7. Nourooz-zadeh J, Tajaddini Sarmadi J, Carthy MCS, et al. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 1995; 44(9): 1054-1058.
  8. Osilesi O, Trout DL, Ogunwole JO, Glover EE. Blood pressure and plasma lipids during ascorbic acid supplementation in borderline hypertensive and normotensive adults. Nutr Res 1991;11:405?12
  9. Sauberlich,H.E., Green M. D. and Omaye S. T. (1982): Determination of ascorbic acid and dehydro-ascorbic acid. In: ascorbic acid: chemistry, metabolism, and uses (p.a.seibandb.m.tolbert,eds.) , Advancesinchemistryseries200,pp.199-221. American chemical society : Washington, D.C.
  10. Taddei S., Virdis A., Ghiadoni L., Magagna A., Salvetti A. Vitamin C improves endothelium dependant vasodilatation by restoring nitric oxide activity in essential hypertension. Circulation. 1998;97:2222?2224.
  11. US Department of Health and Human Services UPHS, Centers for Disease Control, Clinical Chemistry Division: Laboratory procedures used by the clinical chemistry division, for the second national health and nutrition examination survey (NHANES II) 1976?1980. IV-analytical methods, vitamin C. 1979, Atlanta, GA: Centers for Disease Control.

[Deepali M Vaishnav, Manjusha D Hivre and Shrirang R Holkar (2019); VITAMIN C AS A MARKER OF OXIDATIVE STRESS IN HYPERTENSION Int. J. of Adv. Res. 7 (Dec). 320-322] (ISSN 2320-5407). www.journalijar.com


Dr Deepali M Vaishnav
Department of Biochemistry , MGM Medical College, Aurangabad

DOI:


Article DOI: 10.21474/IJAR01/10157      
DOI URL: https://dx.doi.org/10.21474/IJAR01/10157